Predictive biomarkers for Alzheimer's disease using state-of-the-art brain imaging techniques

Journal of Alzheimer's Disease

Volumn 31, Issue SUPPL. 3, 2012, Pages

  Mandal, Pravat K ^a,b  

^a Neurospectroscopy and Neuroimaging Laboratory   (India)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; DONEPEZIL; PHOSPHORUS 31; TAU PROTEIN;

ALZHEIMER DISEASE; ART; ARTERIAL SPIN LABELING; BRAIN; BRAIN BLOOD FLOW; BRAIN COMPUTER INTERFACE; BRAIN FUNCTION; CEREBROSPINAL FLUID CYTOLOGY; COGNITION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFUSION TENSOR IMAGING; DRUG EFFICACY; FRACTIONAL ANISOTROPY; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE QUALITY; IN VIVO STUDY; LIFE EXPECTANCY; MILD COGNITIVE IMPAIRMENT; NEUROCHEMISTRY; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SPIN LABELING; VOLUMETRY; VOXEL BASED MORPHOMETRY;

EID: 84866846219     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120731     Document Type: Review

References (12)

1. Lopez OL, Becker JT, Klunk W, Saxton J, Hamilton RL, Kaufer DI, Sweet RA, Cidis Meltzer C, Wisniewski S, Kamboh MI, DeKosky ST (2000) Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology 55, 1854-1862.
2. Fox NC, Freeborough PA (1997) Brain atrophy progression measured from registered serial MRI: Validation and application to Alzheimer's disease. J Magn Reson Imaging 7, 1069-1075.
3. Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G (2007) Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 130, 1767-1776.
4. Mandal PK, Tripathi M, Sugunan S (2012) Brain oxidative stress: Detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. Biochem Biophys Res Commun 417, 43-48.
5. Mandal PK (2007) Magnetic resonance spectroscopy (MRS) and its application in Alzheimer's disease. Concepts Magn Reson Part A Bridg Educ Res 30, 40-64.
6. Shonk TK, Moats RA, Gifford P, Michaelis T, Mandigo JC, Izumi J, Ross BD (1995) Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195, 65-72.
7. Kantarci K, Petersen RC, Przybelski SA,Weigand SD, Shiung MM, Whitwell JL, Negash S, Ivnik RJ, Boeve BF, Knopman DS, Smith GE, Jack CR Jr (2008) Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol 65, 1621-1628.
8. Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS (2003) fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 74, 44- 50.
9. Butters MA, Klunk WE, Mathis CA, Price JC, Ziolko SK, Hoge JA, Tsopelas ND, Lopresti BJ, Reynolds CF 3rd, DeKosky ST, Meltzer CC (2008) Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B. Alzheimer Dis Assoc Disord 22, 261-268.
10. Alsop DC, Detre JA, Grossman M (2000) Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 47, 93-100.
11. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ,WeinerMW, Jack CR Jr, JaustW, Toga AW, Lee VM, Shaw LM (2010) Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement 6, 230-238.
12. Mandal PK (2012) In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites. Eur J Radiol 81, e653-e664.